A Study of CSPCHA131 in Patients With Advanced Solid Tumor
Status:
Recruiting
Trial end date:
2021-04-12
Target enrollment:
Participant gender:
Summary
The study was designed to evaluate the safety, tolerability, pharmacokinetics, and
preliminary antitumor activity of CSPCHA131 alone or plus chemotherapy in patients with
advanced solid tumors.